Effects of converting enzyme inhibitors: ramipril and enalapril on peptide action and sympathetic neurotransmission in the isolated heart
- PMID: 2995065
- DOI: 10.1016/0014-2999(85)90738-1
Effects of converting enzyme inhibitors: ramipril and enalapril on peptide action and sympathetic neurotransmission in the isolated heart
Abstract
The role of converting enzyme (CE) in heart function was studied by assessing the inhibition of CE activity in rat heart tissue and in isolated perfused hearts from rat, guinea-pig and rabbit (Langendorff technique). Angiotensin I (ANG I) added to the perfusate reduced coronary flow (FLO) in all species, increased force of contraction (CON) in rats, decreased CON in guinea-pigs and had no effect on CON in rabbits. In contrast, bradykinin (BK) increased FLO in all species, decreased CON in rats, increased CON in guinea-pigs and had no effect on CON in rabbits. The CE inhibitors ramipril (HOE498) 1 mg/kg and enalapril (MK421) 30 mg/kg given orally 1 h prior to killing of the animals inhibited the ANG I effects and potentiated the BK effects but had no effects on the action of ANG II. The same doses of the two CE inhibitors produced up to 24 h inhibition of CE activity measured biochemically in the heart after single oral doses. Electrical sympathetic stimulation of the cardiac nerves (SNS) in isolated rabbit heart resulted in an increase of HR and CON and in an initial decrease and subsequent increase of FLO. The effects of SNS on HR and FLO were significantly reduced following HOE498 (1 mg/kg) pretreatment. The results suggest that local CE is involved in the regulation of peptide effects in the heart, including the ANG II-mediated facilitation of neurotransmission.
Similar articles
-
Local inhibition of angiotensin II formation and bradykinin degradation in isolated hearts.Clin Exp Hypertens A. 1988;10(6):1259-70. doi: 10.1080/07300077.1988.11878916. Clin Exp Hypertens A. 1988. PMID: 2975971
-
Cardiac arrhythmias are ameliorated by local inhibition of angiotensin formation and bradykinin degradation with the converting-enzyme inhibitor ramipril.Cardiovasc Drugs Ther. 1989 Dec;3(6):873-82. doi: 10.1007/BF01869575. Cardiovasc Drugs Ther. 1989. PMID: 2535056
-
Is tissue converting enzyme inhibition a determinant of the antihypertensive efficacy of converting enzyme inhibitors? Studies with the two different compounds, Hoe498 and MK421, in spontaneously hypertensive rats.J Cardiovasc Pharmacol. 1984 Sep-Oct;6(5):872-80. doi: 10.1097/00005344-198409000-00021. J Cardiovasc Pharmacol. 1984. PMID: 6209494
-
Pharmacological interference with the cardiac renin-angiotensin system.J Cardiovasc Pharmacol. 1989;14 Suppl 4:S10-5. J Cardiovasc Pharmacol. 1989. PMID: 2483422 Review.
-
Influence of angiotensin-converting enzyme inhibition on sympathetic neurotransmission: possible roles of bradykinin and prostaglandins.J Cardiovasc Pharmacol. 1992;20 Suppl 9:S39-46. J Cardiovasc Pharmacol. 1992. PMID: 1282628 Review.
Cited by
-
Ramipril. A review of its pharmacological properties and therapeutic efficacy in cardiovascular disorders.Drugs. 1990 Jan;39(1):110-35. doi: 10.2165/00003495-199039010-00009. Drugs. 1990. PMID: 2138076 Review.
-
Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.Drugs. 1986 Mar;31(3):198-248. doi: 10.2165/00003495-198631030-00002. Drugs. 1986. PMID: 3011386 Review.
-
Induction of cardiac angiotensin I-converting enzyme with dietary NaCl-loading in genetically hypertensive and normotensive rats.J Mol Med (Berl). 1995 May;73(5):243-8. doi: 10.1007/BF00189924. J Mol Med (Berl). 1995. PMID: 7670928
-
Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. Effects on coronary resistance, contractility, and relaxation.J Clin Invest. 1990 Dec;86(6):1913-20. doi: 10.1172/JCI114924. J Clin Invest. 1990. PMID: 2174912 Free PMC article.
-
Dual action of angiotensin II on coronary resistance in the isolated perfused rabbit heart.Naunyn Schmiedebergs Arch Pharmacol. 1993 Dec;348(6):650-8. doi: 10.1007/BF00167243. Naunyn Schmiedebergs Arch Pharmacol. 1993. PMID: 7510856
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous